pubmed.ncbi.nlm.nih.gov

Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment - PubMed

Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment

Derek Gillen et al. Gastroenterology. 2004 Apr.

Erratum in

Gastroenterology. 2004 Aug;127(2):694

Abstract

Background & aims: Rebound increased acid secretion has been observed at 2 weeks after discontinuing omeprazole treatment in Helicobacter pylori -negative, but not H. pylori -positive, subjects. It is unknown whether this is a prolonged phenomenon or whether a similar phenomenon appears later in H. pylori positives or is released by eradication therapy. The aims of this study were to answer these 3 questions.

Methods: Twelve H. pylori -negative and 20 H. pylori -positive subjects were studied. Each had a basal, submaximal, and maximal pentagastrin-stimulated acid secretion study before, during, and at 7, 14, 28, 42, and 56 days after a 56-day course of omeprazole 40 mg/day. Ten of the H. pylori -positive subjects had their infection eradicated during the last week of treatment.

Results: In the H. pylori -negative subjects, there was rebound secretion of submaximal (P < 0.003) and maximal (P < 0.003) acid output, which persisted until at least 56 days after discontinuing omeprazole. The H. pylori -uneradicated subjects had no rebound increased secretion other than in maximal acid output at 28 (P < 0.01) and at 42 days after treatment (P < 0.02). In those eradicated of H. pylori close to the end of omeprazole, there was rebound increased secretion of submaximal acid output (P < 0.04) lasting until 56 days and of maximal acid output (P < 0.01) lasting until 28 days after treatment.

Conclusions: Rebound increased acid secretion following omeprazole is a prolonged phenomenon in H. pylori -negative subjects. There is little evidence of it in H. pylori -infected subjects, but eradicating the infection releases the phenomenon. The accentuated H. pylori -related oxyntic gastritis induced by omeprazole is likely to protect against the rebound phenomenon.

PubMed Disclaimer

Cited by

Pharmacokinetic drug interaction profiles of proton pump inhibitors.
Blume H, Donath F, Warnke A, Schug BS. Blume H, et al. Drug Saf. 2006;29(9):769-84. doi: 10.2165/00002018-200629090-00002. Drug Saf. 2006. PMID: 16944963 Review.
The effect of intragastric ammonia production on titratable gastric acid output in Helicobacter pylori-infected patients with chronic gastritis.
Cylwik B, Dlugosz JW, Kemona A, Szmitkowski M. Cylwik B, et al. Dig Dis Sci. 2005 Nov;50(11):2094-9. doi: 10.1007/s10620-005-3013-y. Dig Dis Sci. 2005. PMID: 16240221
Helicobacter pylori eradication induces marked increase in H+/K+-adenosine triphosphatase expression without altering parietal cell number in human gastric mucosa.
Osawa H, Kita H, Ohnishi H, Hoshino H, Mutoh H, Ishino Y, Watanabe E, Satoh K, Sugano K. Osawa H, et al. Gut. 2006 Feb;55(2):152-7. doi: 10.1136/gut.2005.066464. Epub 2005 May 4. Gut. 2006. PMID: 15872000 Free PMC article.
Review article: oesophageal complications and consequences of persistent gastro-oesophageal reflux disease.
Pisegna J, Holtmann G, Howden CW, Katelaris PH, Sharma P, Spechler S, Triadafilopoulos G, Tytgat G. Pisegna J, et al. Aliment Pharmacol Ther. 2004 Dec;20 Suppl 9(Suppl 9):47-56. doi: 10.1111/j.1365-2036.2004.02240.x. Aliment Pharmacol Ther. 2004. PMID: 15527464 Free PMC article. Review.
A pharmacological approach to gastric acid inhibition.
Esplugues JV. Esplugues JV. Drugs. 2005;65 Suppl 1:7-12. doi: 10.2165/00003495-200565001-00003. Drugs. 2005. PMID: 16335853 Review.

Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment - PubMed